These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
573 related articles for article (PubMed ID: 15029514)
1. [Modification of clinical profile of stroke in atrial fibrillation patients. Effect of antithrombotic treatment]. García Escrivà A; López Hernández N; Hernández Lorido R; Oliver Navarrete C; Bustos S; Carneado Ruiz J; Gracia Fleta F; Moltó Jordá JM Rev Neurol; 2004 Mar 1-15; 38(5):401-5. PubMed ID: 15029514 [TBL] [Abstract][Full Text] [Related]
2. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]). Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959 [TBL] [Abstract][Full Text] [Related]
3. [Adequacy of anticoagulant prevention in patients with atrial fibrillation]. García-García J; Calleja-Puerta S; de la Vega-Cerezales V; Benavente-Fernández L; Rodríguez-Rodríguez S; Hernández-Lahoz C Rev Neurol; 2005 Oct 1-15; 41(7):399-403. PubMed ID: 16193445 [TBL] [Abstract][Full Text] [Related]
4. Stratification with CHA2DS2-VASc score is better than CHADS2 score in reducing ischemic stroke risk in patients with atrial fibrillation. Pieri A; Lopes TO; Gabbai AA Int J Stroke; 2011 Oct; 6(5):466. PubMed ID: 21951414 [No Abstract] [Full Text] [Related]
5. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment. Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006. Béjot Y; Ben Salem D; Osseby GV; Couvreur G; Durier J; Marie C; Cottin Y; Moreau T; Giroud M Neurology; 2009 Jan; 72(4):346-53. PubMed ID: 19171832 [TBL] [Abstract][Full Text] [Related]
7. Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation. Yu HC; Tsai YF; Chen MC; Yeh CH Int J Stroke; 2012 Feb; 7(2):112-7. PubMed ID: 22103748 [TBL] [Abstract][Full Text] [Related]
9. [Social impact of stroke due to atrial fibrillation]. Santamarina E; Alvarez Sabín J Neurologia; 2012 Mar; 27 Suppl 1():10-4. PubMed ID: 22682205 [TBL] [Abstract][Full Text] [Related]
10. Changes in risk factors and preventive treatments by stroke subtypes over 20 years: a population-based study. Béjot Y; Osseby GV; Gremeaux V; Durier J; Rouaud O; Moreau T; Giroud M J Neurol Sci; 2009 Dec; 287(1-2):84-8. PubMed ID: 19766250 [TBL] [Abstract][Full Text] [Related]
11. [Cardioembolic infarction: clinical course and characteristics]. Santos-Lasaosa S; Navas I; Mostacero E; López del Val J; Tejero C; Escalza I Rev Neurol; 2000 Dec 16-31; 31(12):1154-8. PubMed ID: 11205549 [TBL] [Abstract][Full Text] [Related]
12. Comorbidity associated with atrial fibrillation: a general practice-based study. Carroll K; Majeed A Br J Gen Pract; 2001 Nov; 51(472):884-6, 889-91. PubMed ID: 11761201 [TBL] [Abstract][Full Text] [Related]
13. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ; Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203 [TBL] [Abstract][Full Text] [Related]
14. Rate of antithrombotic drug use and clinical outcomes according to CHADS2 scores in patients with an initial cardioembolic stroke who had nonvalvular atrial fibrillation. Deguchi I; Ogawa H; Ohe Y; Nemoto M; Tanahashi N J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):846-50. PubMed ID: 22819543 [TBL] [Abstract][Full Text] [Related]
15. Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome? Chitravas N; Dewey HM; Nicol MB; Harding DL; Pearce DC; Thrift AG Neurology; 2007 May; 68(20):1687-93. PubMed ID: 17502550 [TBL] [Abstract][Full Text] [Related]
16. Paroxysmal atrial fibrillation is more prevalent than persistent atrial fibrillation in acute stroke and transient ischemic attack patients. Rizos T; Wagner A; Jenetzky E; Ringleb PA; Becker R; Hacke W; Veltkamp R Cerebrovasc Dis; 2011; 32(3):276-82. PubMed ID: 21893980 [TBL] [Abstract][Full Text] [Related]
17. Prestroke anticoagulation and paroxysmal type are correlated with favorable outcome in ischemic stroke patients with atrial fibrillation. Hoshino H; Itoh Y; Kimura H; Miyaki K; Suzuki N J Stroke Cerebrovasc Dis; 2012 Jan; 21(1):11-7. PubMed ID: 20833081 [TBL] [Abstract][Full Text] [Related]
18. Cerebral microbleeds are common in ischemic stroke but rare in TIA. Werring DJ; Coward LJ; Losseff NA; Jäger HR; Brown MM Neurology; 2005 Dec; 65(12):1914-8. PubMed ID: 16380612 [TBL] [Abstract][Full Text] [Related]
19. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study. Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184 [TBL] [Abstract][Full Text] [Related]
20. The prescribing patterns of antithrombotic agents for prevention of recurrent ischemic stroke. Po HL; Lin YJ; Hseuh IH Acta Neurol Taiwan; 2009 Jun; 18(2):98-103. PubMed ID: 19673361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]